Novartis (Symbol: NVS) has been named to the Dividend Channel ”International S.A.F.E. 10” list, signifying an international stock with above-average ”DividendRank”statistics including a strong 3.2% yield, as well as a superb track record of at least five years of dividend growth, according to the most recent ”DividendRank” report.
According to the ETF Finder at ETF Channel , Novartis is an underlying holding representing 1.45% of the Powershares International Dividend Achievers ETF ( PID ), which holds $12,345,394 worth of NVS shares. Novartis (Symbol: NVS) made the “Dividend Channel International S.A.F.E. 10” list because of these qualities: S . Solid return – hefty yield and strong DividendRank characteristics; A. Accelerating amount – consistent dividend increases over time; F . Flawless five year history – never a missed or lowered dividend; E. Enduring – at least a half-decade of dividend payments.
The annualized dividend paid by Novartis is $2.75/share, currently paid in annual installments, and its most recent dividend ex-date was on 03/01/2017.
NVS operates in the Drugs & Pharmaceuticals sector, among companies like Johnson & Johnson ( JNJ), and Pfizer Inc ( PFE ).
Big Pharma has long seen the potential for AI and machine learning to accelerate drug development. But Novo Nordisk is going a step further by channeling $200 million toward the creation of a computer that will outrun anything in existence.
Current methods for diagnosing Alzheimer’s disease rely on a complex combination of self- and caregiver-reported symptoms, a physical examination and either a PET scan or a spinal tap to look for evidence of amyloid plaque build-ups in the brain. But a new artificial intelligence-based method may make the diagnostic process a much more objective one.
There is lots of talk about diversity and inclusion in business, including in pharma and medtech. A new report by the Open Political Economy Network (OPEN), a think tank focusing on migration and diversity, released its “Minority Businesses Matter: Europe” report highlighting the successes and challenges of ethnic minority-owned businesses in Europe.